Historique
Bulletin de Périodique
Current Pharmaceutical Design , Vol.17, n°14 - May 2011 - Pharmacological treatments of alcohol and drug addiction: What's new?
Auteur(s) :
L. KARILA, Éditeur scientifique
Paru le :
01/05/2011
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Pharmacological treatments of alcohol and drug addiction: what's new? Karila L., p. 1320.
• From substance dependence to addiction: impact of a conceptual shift on therapeutic approaches? Reynaud M., Karila L., p. 1321-1322.
• Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Edwards S., Kenna G.A., Swift R.M., Leggio L., p. 1323-1332.
• Pharmaceutical approaches of binge drinking. Rolland B., Karila L., Guardia D., Cottencin O., p. 1333-1342.
• Pharmacotherapy for smoking cessation: present and future. Aubin H.J., Karila L., Reynaud M., p. 1343-1350.
• Pharmacological treatment of cannabis dependence. Weinstein A.M., Gorelick D.A., p. 1351-1358.
• Pharmacological treatments for cocaine dependence: is there something new? Karila L., Reynaud M., Aubin H.J., Rolland B., Guardia D., Cottencin O., et al., p. 1359-1368.
• The reliability and validity of the French version of the Cocaine Craving Questionnaire-Brief. Karila L., Seringe E., Benyamina A., Reynaud M., p. 1369-1375.
• Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. Meini M., Moncini M., Cecconi D., Cellesi V., Biasci L., Simoni G., et al., p. 1376-1383.
• Pharmacological treatments of opiate dependence. Benyamina A., Reynaud M., Blecha L., Karila L., p. 1384-1388.
• Psychopharmacological treatment in pathological gambling: a critical review. Achab S., Khazaal Y., p. 1389-1395.
• GABAergic and glutamatergic modulation in binge eating: therapeutic approach. Guardia D., Rolland B., Karila L., Cottencin O., p. 1396-1409.
• The potential interest of topiramate in addiction. Thorens G., Billieux J., Manghi R., Khan R., Khazaal Y., Zullino D.F., p. 1410-1415.
• Pharmacological treatments of alcohol and drug addiction: what's new? Karila L., p. 1320.
• From substance dependence to addiction: impact of a conceptual shift on therapeutic approaches? Reynaud M., Karila L., p. 1321-1322.
• Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Edwards S., Kenna G.A., Swift R.M., Leggio L., p. 1323-1332.
• Pharmaceutical approaches of binge drinking. Rolland B., Karila L., Guardia D., Cottencin O., p. 1333-1342.
• Pharmacotherapy for smoking cessation: present and future. Aubin H.J., Karila L., Reynaud M., p. 1343-1350.
• Pharmacological treatment of cannabis dependence. Weinstein A.M., Gorelick D.A., p. 1351-1358.
• Pharmacological treatments for cocaine dependence: is there something new? Karila L., Reynaud M., Aubin H.J., Rolland B., Guardia D., Cottencin O., et al., p. 1359-1368.
• The reliability and validity of the French version of the Cocaine Craving Questionnaire-Brief. Karila L., Seringe E., Benyamina A., Reynaud M., p. 1369-1375.
• Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. Meini M., Moncini M., Cecconi D., Cellesi V., Biasci L., Simoni G., et al., p. 1376-1383.
• Pharmacological treatments of opiate dependence. Benyamina A., Reynaud M., Blecha L., Karila L., p. 1384-1388.
• Psychopharmacological treatment in pathological gambling: a critical review. Achab S., Khazaal Y., p. 1389-1395.
• GABAergic and glutamatergic modulation in binge eating: therapeutic approach. Guardia D., Rolland B., Karila L., Cottencin O., p. 1396-1409.
• The potential interest of topiramate in addiction. Thorens G., Billieux J., Manghi R., Khan R., Khazaal Y., Zullino D.F., p. 1410-1415.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
M. REYNAUD ;
L. KARILA
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Switching from the concept of substance or alcohol dependence to that of addiction has profoundly modified our ways of approaching, treating and organizing the care of this disease. This more complex and subtle approach gives less importance to [...]
S. M. EDWARDS ;
G. A. KENNA ;
R. M. SWIFT ;
L. LEGGIO
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Harmful alcohol use is a risk factor in more than 60 diseases and injuries resulting in approximately 2.5 million deaths per year worldwide. In the United States (US) and Europe, there are only a few medications approved for alcohol dependence ([...]
B. ROLLAND ;
L. KARILA ;
D. GUARDIA ;
O. COTTENCIN
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Binge Drinking (BD) is often considered to be recurrent alcohol abuse amongst adolescents and young adults. However, the close link between adolescence and impulsivity has led many authors to define BD as intoxication-seeking behaviour. Medicati[...]
H. J. AUBIN ;
L. KARILA ;
M. REYNAUD
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Tobacco dependence is a chronic disease that often requires repeated interventions and multiple attempts to quit. To date, three medications are FDA-approved for smoking cessation: nicotine replacement therapy, sustained-release bupropion, and v[...]
A. M. WEINSTEIN ;
D. A. GORELICK
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Cannabis is the most frequently used illegal psychoactive substance in the world. There is a significant increase in the number of treatment admissions for cannabis use disorders in the past few years, and the majority of cannabis-dependent indi[...]
L. KARILA ;
M. REYNAUD ;
H. J. AUBIN ;
B. ROLLAND ;
D. GUARDIA ;
O. COTTENCIN ;
A. BENYAMINA
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
INTRODUCTION: There is no specific and approved treatment, by regulatory authorities, for cocaine dependence. Therefore, developing new medications for the treatment of this disease continues to be a research priority. Recent advances in neurobi[...]
L. KARILA ;
E. SERINGE ;
A. BENYAMINA ;
M. REYNAUD
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
INTRODUCTION: Cocaine has become a noticeable part of the European drug scene and is the second most commonly used illicit drug among the general population. Craving is a core issue in cocaine dependence and is strongly associated with lapse and[...]
M. MEINI ;
M. MONCINI ;
D. CECCONI ;
V. CELLESI ;
L. BIASCI ;
G. SIMONI ;
M. AMEGLIO ;
M. PELLEGRINI ;
R. N. FORGIONE ;
P. RUCCI
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
BACKGROUND: Currently, there is no specific pharmacological therapy with established efficacy for the treatment of cocaine dependence. The aim of this study was to determine the safety, tolerability and the effects of aripiprazole and ropinirole[...]
A. BENYAMINA ;
M. REYNAUD ;
L. BLECHA ;
L. KARILA
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Opiate substitution therapies have largely contributed to improving outcomes in opiate dependent patients. Their impact has significantly diminished HIV transmission rates, decreased incidence of overdose and reduced delinquency due to heroin tr[...]
S. ACHAB ;
Y. KHAZAAL
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Given the rates of pathological gambling and its impact on affected individuals and their relatives, effective treatments are needed. There are, however, no approved pharmacological treatments for pathological gambling. This paper describes the [...]
G. THORENS ;
J. BILLIEUX ;
R. MANGHI ;
R. KHAN ;
Y. KHAZAAL ;
D. F. ZULLINO
|
2011
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Dans Current Pharmaceutical Design (Vol.17, n°14, May 2011) Article : Périodique
Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuo[...]